Neurofilament light chain (NfL), a neuron-specific cytoskeletal protein, is a promising biomarker for axonal damage and neurodegeneration that offers relevant insights into the pathology underlying MS [23]. The gene discussed is NEFL; the disease is myeloid sarcoma.